Real-time microscopic observation of Candida biofilm development and effects due to micafungin and fluconazole

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 5, 2013, Pages 2226-2230

  Kaneko, Yukihiro ^a   Miyagawa, Susumu ^b   Takeda, On ^b   Hakariya, Masateru ^c   Matsumoto, Satoru ^d   Ohno, Hideaki ^a   Miyazaki, Yoshitsugu ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b CAM Co Ltd   (Japan)

^c Cine Science Laboratory   (Japan)

^d ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; MICAFUNGIN;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; FUNGUS GROWTH; FUNGUS HYPHAE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; YEAST CELL;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; ECHINOCANDINS; ERGOSTEROL; FLUCONAZOLE; GLUCANS; HYPHAE; KINETICS; LIPOPEPTIDES; MICROSCOPY; TIME-LAPSE IMAGING;

EID: 84876212260     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02290-12     Document Type: Article

References (19)

1. Kuhn DM, Ghannoum MA. 2004. Candida biofilms: antifungal resistance and emerging therapeutic options. Curr. Opin. Investig. Drugs 5:186-197.
2. Zirkel J, Klinker H, Kuhn A, Abele-Horn M, Tappe D, Turnwald D, Einsele H, Heinz WJ. 2012. Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors. Med. Mycol. 50:50-55.
3. Zilberberg MD, Kollef MH, Arnold H, Labelle A, Micek ST, Kothari S, Shorr AF. 2010. Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect. Dis. 10:150. doi:10.1186/1471-2334-10-150.
4. Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, Hernday AD, Tuch BB, Andes DR, Johnson AD. 2012. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148:126-138.
5. Seki N, Kasai S, Saito N, Komagata O, Mihara M, Sasaki T, Tomita T, Sasaki T, Kobayashi M. 2007. Quantitative analysis of proliferation and excretion of Bartonella quintana in body lice, Pediculus humanus L. Am. J. Trop. Med. Hyg. 77:562-566.
6. Clinical and Laboratory Standards Institute. 2007. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard, 3rd ed. CLSI document M27-A3. CLSI, Wayne, PA.
7. Azuma J, Nakahara K, Kagayama A, Okuma T, Kawamura A, Mukai T. 2002. Pharmacokinetic study of micafungin. Jpn. J. Chemother. 50(S-1): 155-184.
8. Sobue S, Tan K, Layton G, Eve M, Sanderson JB. 2004. Pharmacokinetics of fosfluconazole and fluconazole following multiple intravenous administration of fosfluconazole in healthy male volunteers. Br. J. Clin. Pharmacol. 58:20-25.
9. Baillie GS, Douglas LJ. 1998. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob. Agents Chemother. 42:1900-1905.
10. Lafleur MD, Qi Q, Lewis K. 2010. Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob. Agents Chemother. 54:39-44.
11. Purevdorj-Gage B, Costerton WJ, Stoodley P. 2005. Phenotypic differentiation and seeding dispersal in non-mucoid and mucoid Pseudomonas aeruginosa biofilms. Microbiology 151:1569-1576.
12. Blankenship JR, Mitchell AP. 2006. How to build a biofilm: a fungal perspective. Curr. Opin. Microbiol. 9:588-594.
13. Uppuluri P, Pierce CG, Thomas DP, Bubeck SS, Saville SP, Lopez-Ribot JL. 2010. The transcriptional regulator Nrg1p controls Candida albicans biofilm formation and dispersion. Eukaryot. Cell 9:1531-1537.
14. Kaneko Y, Ohno H, Fukazawa H, Murakami Y, Imamura Y, Kohno S, Miyazaki Y. 2010. Anti-Candida-biofilm activity of micafungin is attenuated by voriconazole but restored by pharmacological inhibition of Hsp90-related stress responses. Med. Mycol. 48:606-612.
15. Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45:2475-2479.
16. Kaneko Y, Ohno H, Kohno S, Miyazaki Y. 2010. Micafungin alters the expression of genes related to cell wall integrity in Candida albicans biofilms. Jpn. J. Infect. Dis. 63:355-357.
17. Mukherjee PK, Zhou G, Munyon R, Ghannoum MA. 2005. Candida biofilm: a well-designed protected environment. Med. Mycol. 43:191-208.
18. Valentín A, Canton E, Peman J, Martinez JP. 2012. Voriconazole inhibits biofilm formation in different species of the genus Candida. J. Antimicrob. Chemother. 67:2418-2423.
19. Ramage G, VandeWalle K, Bachmann SP, Wickes BL, Lopez-Ribot JL. 2002. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob. Agents Chemother. 46:3634-3636.